Cargando…
Oncogenic RUNX3: A Link between p53 Deficiency and MYC Dysregulation
The RUNX transcription factors serve as master regulators of development and are frequently dysregulated in human cancers. Among the three family members, RUNX3 is the least studied, and has long been considered to be a tumor-suppressor gene in human cancers. This idea is mainly based on the observa...
Autores principales: | Date, Yuki, Ito, Kosei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057839/ https://www.ncbi.nlm.nih.gov/pubmed/31991537 http://dx.doi.org/10.14348/molcells.2019.0285 |
Ejemplares similares
-
p53 Deficiency-Dependent Oncogenicity of Runx3
por: Ito, Kosei, et al.
Publicado: (2023) -
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
por: Selvarajan, V, et al.
Publicado: (2017) -
RUNX1 Dosage in Development and Cancer
por: Lie-a-ling, Michael, et al.
Publicado: (2020) -
RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
por: Oei, Vincent, et al.
Publicado: (2023) -
The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells
por: Chuang, Linda Shyue Huey, et al.
Publicado: (2020)